Axovant Sciences Ltd. 4
4 · Axovant Sciences Ltd. · Filed May 2, 2017
Insider Transaction Report
Form 4
Altmeyer Mark
Pres&Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-04-28+100,000→ 100,000 totalExercise: $24.24Exp: 2027-04-28→ Common Shares (100,000 underlying)
Footnotes (2)
- [F1]This option vests over a period of four years, with one quarter of the common shares underlying the option vesting on April 28, 2018 and the remainder vesting in twelve equal quarterly installments thereafter. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- [F2]Includes only options with the same termination date.